688319 欧林生物
交易中 07-22 10:19:02
资讯
新帖
简况
幽门螺杆菌概念盘中拉升,亚太药业涨3.50%
市场透视 · 39分钟前
幽门螺杆菌概念盘中拉升,亚太药业涨3.50%
欧林生物涨5.32% 资金博弈加剧估值分歧技术突破构筑价值中枢
智选洞察 · 07-21 02:57
欧林生物涨5.32% 资金博弈加剧估值分歧技术突破构筑价值中枢
欧林生物中标攀枝花疫苗项目 券商看好买入评级股价大涨
自选股中标信息 · 07-19 11:09
欧林生物中标攀枝花疫苗项目 券商看好买入评级股价大涨
7月18日欧林生物涨18.93%,兴全社会价值三年持有混合基金重仓该股
证券之星 · 07-18
7月18日欧林生物涨18.93%,兴全社会价值三年持有混合基金重仓该股
创新药概念股拉升 欧林生物、金城医药涨超10%
E公司 · 07-18
创新药概念股拉升 欧林生物、金城医药涨超10%
欧林生物涨5.50% 资金博弈与估值分化推动股价波动
智选洞察 · 07-18
欧林生物涨5.50% 资金博弈与估值分化推动股价波动
欧林生物涨5.18% 技术壁垒支撑与资金流入共振
智选洞察 · 07-11
欧林生物涨5.18% 技术壁垒支撑与资金流入共振
欧林生物:深耕创新疫苗领域 打造国际化生物制药企业
中国财富通 · 07-09
欧林生物:深耕创新疫苗领域 打造国际化生物制药企业
欧林生物股价跌5.04%创近一个月新低 资金博弈加剧估值压力
智选洞察 · 07-07
欧林生物股价跌5.04%创近一个月新低 资金博弈加剧估值压力
欧林生物涨5.10% 技术壁垒强化管线突破重塑价值逻辑
智选洞察 · 07-03
欧林生物涨5.10% 技术壁垒强化管线突破重塑价值逻辑
中国创新药能否持续让世界买单?券商分析师最新观点
券商中国 · 06-30
中国创新药能否持续让世界买单?券商分析师最新观点
每周股票复盘:欧林生物(688319)以简易程序向特定对象发行A股股票
证券之星 · 06-29
每周股票复盘:欧林生物(688319)以简易程序向特定对象发行A股股票
欧林生物获战略投资
亿欧网 · 06-26
欧林生物获战略投资
欧林生物06月25日遭主力抛售852.9万元
市场透视 · 06-25
欧林生物06月25日遭主力抛售852.9万元
欧林生物06月23日主力净流入417.2万元 散户资金抛售
市场透视 · 06-23
欧林生物06月23日主力净流入417.2万元 散户资金抛售
欧林生物06月20日主力净流出168.7万元 散户资金买入
市场透视 · 06-20
欧林生物06月20日主力净流出168.7万元 散户资金买入
生物制品行业深度报告:MNC加速布局减重降糖千亿美金赛道,开启BD黄金窗口期
开源证券 · 06-20
生物制品行业深度报告:MNC加速布局减重降糖千亿美金赛道,开启BD黄金窗口期
欧林生物06月19日主力净流入1101.5万元 散户资金抛售
市场透视 · 06-19
欧林生物06月19日主力净流入1101.5万元 散户资金抛售
欧林生物06月18日主力净流出59.3万元 散户资金买入
市场透视 · 06-18
欧林生物06月18日主力净流出59.3万元 散户资金买入
最火赛道再迎重磅利好,创新药行情还能持续多久?
券商中国 · 06-16
最火赛道再迎重磅利好,创新药行情还能持续多久?
加载更多
公司概况
公司名称:
成都欧林生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2021-06-08
主营业务:
成都欧林生物科技股份有限公司的主营业务是人用疫苗的研发、生产及销售。公司的主要产品是吸附破伤风疫苗、b型流感嗜血杆菌结合疫苗、A群C群脑膜炎球菌多糖结合疫苗。公司入选“中国品牌价值评价”,获得“中国产学研合作创新奖”“2023年度生产力促进(创新发展)二等奖”,并被评为“四川省技术创新示范企业”“2023年度四川省医药企业50强”。公司“严重致病菌疫苗关键技术创立及推广应用”获评“重庆市科技进步一等奖”。
发行价格:
9.88
{"stockData":{"symbol":"688319","market":"SH","secType":"STK","nameCN":"欧林生物","latestPrice":23.8,"timestamp":1753150742000,"preClose":22.58,"halted":0,"volume":11098044,"delay":0,"changeRate":0.054,"floatShares":405000000,"shares":405999999,"eps":0.0978,"marketStatus":"交易中","change":1.22,"latestTime":"07-22 10:19:02","open":22.4,"high":24.6,"low":22.4,"amount":260000000,"amplitude":0.0974,"askPrice":23.82,"askSize":2,"bidPrice":23.8,"bidSize":76,"shortable":0,"etf":0,"ttmEps":0.0978,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1753155000000},"marketStatusCode":2,"adr":0,"adjPreClose":22.58,"symbolType":"stock_kcb","openAndCloseTimeList":[[1753147800000,1753155000000],[1753160400000,1753167600000]],"highLimit":24.84,"lowLimit":20.32,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":405933600,"isCdr":false,"pbRate":9.97,"roa":"--","peRate":243.353783,"roe":"--","epsLYR":0.0512,"committee":-0.61302,"marketValue":9661000000,"turnoverRate":0.0274,"status":0,"floatMarketCap":9649000000},"requestUrl":"/m/hq/s/688319","defaultTab":"news","newsList":[{"id":"2553288202","title":"幽门螺杆菌概念盘中拉升,亚太药业涨3.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553288202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553288202?lang=zh_cn&edition=full","pubTime":"2025-07-22 09:40","pubTimestamp":1753148429,"startTime":"0","endTime":"0","summary":"07月22日,幽门螺杆菌概念盘中拉升,截至09点40分,幽门螺杆菌概念整体指数上涨0.52%,报1128.060点。从个股上来看,该概念的成分股中,亚太药业涨3.50%,康芝药业、悦康药业、欧林生物涨幅居前。从资金上来看,截止发稿,幽门螺杆菌概念概念主力净流入为-1.50亿,其中浙江震元受到资金热捧,主力净流入990.66万;拉长时间线来看,该板块近20日主力资金净流入-52.61亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072209402997afb627&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072209402997afb627&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["002370","BK0132","688319","BK0239"],"gpt_icon":0},{"id":"2553428887","title":"欧林生物涨5.32% 资金博弈加剧估值分歧技术突破构筑价值中枢","url":"https://stock-news.laohu8.com/highlight/detail?id=2553428887","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553428887?lang=zh_cn&edition=full","pubTime":"2025-07-21 10:57","pubTimestamp":1753066642,"startTime":"0","endTime":"0","summary":"欧林生物股价大幅上涨,最新价22.76元/股,涨幅达5.32%。资金博弈加剧估值分歧欧林生物近期净流入主要源于资金面的高频切换。动态市盈率攀升至232.84倍,较生物制品行业均值溢价显著,与2025年前三季度预亏707万元的业绩预告形成估值背离,加剧投资者分歧。技术突破与产业化进程构筑价值中枢核心产品吸附破伤风疫苗贡献超90%营收,2025年一季度营收同比增长23.58%,亏损同比收窄72.79%,显示主营业务造血能力持续改善。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721105727a6b6ad0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721105727a6b6ad0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688319","BK0239"],"gpt_icon":0},{"id":"2552411746","title":"欧林生物中标攀枝花疫苗项目 券商看好买入评级股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2552411746","media":"自选股中标信息","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552411746?lang=zh_cn&edition=full","pubTime":"2025-07-19 19:09","pubTimestamp":1752923374,"startTime":"0","endTime":"0","summary":"2025年07月19日,据天眼查数据,四川省攀枝花市仁和区2025-2026年度非免疫规划疫苗遴选结果公示显示,中标方为欧林生物,招标方为攀枝花市仁和区疾病预防控制中心,攀枝花市仁和区疾控中心。近半年内,欧林生物获得1家券商积极评价:中信建投证券给予\"买入\"评级。欧林生物主营业务涵盖吸附破伤风疫苗,A群C群脑膜炎球菌多糖结合疫苗,b型流感嗜血杆菌结合疫苗,其他收入之和。截至发稿,欧林生物股价报21.61元,上涨18.93%,成交额至4.51亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719190935a4553bc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250719190935a4553bc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688319","159646"],"gpt_icon":0},{"id":"2552468088","title":"7月18日欧林生物涨18.93%,兴全社会价值三年持有混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2552468088","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552468088?lang=zh_cn&edition=full","pubTime":"2025-07-18 16:19","pubTimestamp":1752826783,"startTime":"0","endTime":"0","summary":"证券之星消息,7月18日欧林生物涨18.93%创60日新高,收盘报21.61元,换手率5.53%,成交量22.42万手,成交额4.51亿元。重仓欧林生物的公募基金请见下表:该股最近90天内共有2家机构给出评级,买入评级2家。根据2025基金Q1季报公募基金重仓股数据,重仓该股的公募基金共5家,其中持有数量最多的公募基金为兴证全球基金的兴全社会价值三年持有混合。兴全社会价值三年持有混合目前规模为14.43亿元,最新净值1.7825,较上一交易日上涨1.52%,近一年上涨47.27%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071800025253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688319"],"gpt_icon":0},{"id":"2552523824","title":"创新药概念股拉升 欧林生物、金城医药涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552523824","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552523824?lang=zh_cn&edition=full","pubTime":"2025-07-18 13:57","pubTimestamp":1752818241,"startTime":"0","endTime":"0","summary":"人民财讯7月18日电,创新药概念股拉升,欧林生物、金城医药涨超10%,昂利康、康辰药业、汉商集团涨停。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718135721a6b15730&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718135721a6b15730&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688319","159992","300233","BK0239","600774","603590","BK0209","BK0028"],"gpt_icon":0},{"id":"2552530654","title":"欧林生物涨5.50% 资金博弈与估值分化推动股价波动","url":"https://stock-news.laohu8.com/highlight/detail?id=2552530654","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552530654?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:38","pubTimestamp":1752802720,"startTime":"0","endTime":"0","summary":"欧林生物股价大幅上涨,最新价19.17元/股,涨跌幅为5.50%。资金博弈与估值分化引发股价波动近期欧林生物资金流向主要受资金面高频切换影响。2025年前三季度预亏707万元的业绩预告,进一步催化了部分投资者的兑现需求。6月以来中证1000指数上涨4.62%,资金向科技成长板块倾斜导致医药板块流动性承压。欧林生物吸附破伤风疫苗市占率超90%,2025年一季度营收同比增长23.58%,亏损同比收窄72.79%,主营业务造血能力持续改善。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718093849a6b0e10a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718093849a6b0e10a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688319"],"gpt_icon":0},{"id":"2550609025","title":"欧林生物涨5.18% 技术壁垒支撑与资金流入共振","url":"https://stock-news.laohu8.com/highlight/detail?id=2550609025","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550609025?lang=zh_cn&edition=full","pubTime":"2025-07-11 10:41","pubTimestamp":1752201707,"startTime":"0","endTime":"0","summary":"欧林生物今日盘中表现强势,截至10点41分,最新价报16.65元/股,上涨5.18%。资金博弈与估值压力共振欧林生物近期股价波动与资金高频切换密切相关。截至7月9日,主力资金近3个交易日累计净流出931万元,但7月11日早盘出现逆转,单日净流入612.8万元,反映多空分歧加剧。技术壁垒与研发兑现重构估值长期来看,欧林生物在创伤救治领域的技术优势仍是核心支撑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711104156a6a2bbfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711104156a6a2bbfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688319"],"gpt_icon":0},{"id":"2550468106","title":"欧林生物:深耕创新疫苗领域 打造国际化生物制药企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2550468106","media":"中国财富通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550468106?lang=zh_cn&edition=full","pubTime":"2025-07-09 15:55","pubTimestamp":1752047700,"startTime":"0","endTime":"0","summary":"疫苗领域日益受到全球制药巨头的重点关注。为此,欧林生物持续开展市场教育,致力于提升全民健康防护意识。在此背景下,欧林生物与陆军军医大学达成战略合作,共同研发金葡菌疫苗。该疫苗若成功问世,将填补世界空白,有望大幅降低抗生素使用量,遏制耐药性蔓延。欧林生物以“超级细菌疫苗”战略为核心,围绕世界卫生组织“12种致命耐药菌”清单构建完整创新管线,在耐药菌疫苗研发领域实现全方位领跑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=6W9Y6FUWsP0%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688319","159646","BK0239"],"gpt_icon":0},{"id":"2549557300","title":"欧林生物股价跌5.04%创近一个月新低 资金博弈加剧估值压力","url":"https://stock-news.laohu8.com/highlight/detail?id=2549557300","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549557300?lang=zh_cn&edition=full","pubTime":"2025-07-07 14:15","pubTimestamp":1751868945,"startTime":"0","endTime":"0","summary":"欧林生物今日股价明显走低,截至14点15分,报15.46元/股,跌幅达5.04%,创近一个月以来新低,成交额7936万元,换手率1.23%。资金博弈加剧估值压力欧林生物近期股价波动与资金面高频切换密切相关。研发突破与产能升级双轮驱动长期来看,欧林生物在创伤救治领域的技术壁垒为其构筑护城河,吸附破伤风疫苗市占率超90%,2025年一季度营收同比增长23.58%,亏损同比收窄72.79%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707141551a69a47fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707141551a69a47fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688319"],"gpt_icon":0},{"id":"2548822029","title":"欧林生物涨5.10% 技术壁垒强化管线突破重塑价值逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2548822029","media":"智选洞察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548822029?lang=zh_cn&edition=full","pubTime":"2025-07-03 13:41","pubTimestamp":1751521295,"startTime":"0","endTime":"0","summary":"欧林生物今日股价明显上涨,截至13点40分,最新价为16.69元/股,涨幅达5.10%。资金博弈与市场风格切换共振欧林生物近期股价波动与主力资金多空博弈密切相关。技术壁垒与管线突破重塑价值逻辑从长期维度观察,欧林生物在创伤救治领域已构建显著优势,吸附破伤风疫苗市占率超90%,2025年一季度营收同比增长23.58%,亏损同比收窄72.79%,核心产品商业化进程持续提速。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703134138a72bf94d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703134138a72bf94d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688319","BK0239"],"gpt_icon":0},{"id":"2547015164","title":"中国创新药能否持续让世界买单?券商分析师最新观点","url":"https://stock-news.laohu8.com/highlight/detail?id=2547015164","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547015164?lang=zh_cn&edition=full","pubTime":"2025-06-30 23:29","pubTimestamp":1751297340,"startTime":"0","endTime":"0","summary":"医药魔方统计,2025年1—5月,中国创新药企对外授权交易总金额已达455亿美元,超过2024年上半年的交易总额,创新药出海授权交易大爆发。亮眼数据的背后,是中国创新药整体水平的强势崛起。“中国创新药产业的研发、临床与生产能力,正处于与国际一线水平接轨的初始阶段。”由于BD数据不及预期,年内大涨明显的创新药企业荣昌生物股价近期大幅回调,从而带动创新药板块整体调整。华泰柏瑞恒生创新药ETF6月中旬以来一度单周下行超过8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233154a7267585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233154a7267585&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603127","601607","688136","06160","600200","600380","600222","603707","600332","600881","603998","688235","688278","688488","600062","600789","600196","600998","603456","600056","688202","688505","688520","ONC","688319","600216","688163","603590","688513","600851","600557","688317","688117","688131","603259","BK0239","688177","600420","600774","688331","688073","688181","688189","600721","600080","600682","603087","688336","600267","600351","600645","603716","688321","600079","688198","600422","600513","600276","688356","688091","600867","605199","603567","688506","159992","688068","601089","600535","603229","600521","603367","688166","688222","600572"],"gpt_icon":0},{"id":"2547047557","title":"每周股票复盘:欧林生物(688319)以简易程序向特定对象发行A股股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2547047557","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547047557?lang=zh_cn&edition=full","pubTime":"2025-06-29 08:27","pubTimestamp":1751156829,"startTime":"0","endTime":"0","summary":"截至2025年6月27日收盘,欧林生物报收于15.75元,较上周的15.82元下跌0.44%。本周,欧林生物6月24日盘中最高价报16.37元。欧林生物当前最新总市值63.93亿元,在生物制品板块市值排名37/50,在两市A股市值排名2433/5151。本周关注点公司公告汇总:欧林生物以简易程序向特定对象发行A股股票,募集资金总额为17529.29万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062900001473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399300","BK0239","159982","688319"],"gpt_icon":0},{"id":"2546754755","title":"欧林生物获战略投资","url":"https://stock-news.laohu8.com/highlight/detail?id=2546754755","media":"亿欧网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546754755?lang=zh_cn&edition=full","pubTime":"2025-06-26 14:01","pubTimestamp":1750917670,"startTime":"0","endTime":"0","summary":"2025年6月25日,成都欧林生物科技股份有限公司宣布完成新一轮战略融资。欧林生物成立于2009年12月11日,是一家专注于人用疫苗研发的高新技术企业。本次战略投资的完成,将进一步推动欧林生物在疫苗研发领域的创新步伐,加速新产品的上市进程,为全球公共卫生事业贡献力量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627060154a71f7a6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627060154a71f7a6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688319"],"gpt_icon":0},{"id":"2546297918","title":"欧林生物06月25日遭主力抛售852.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546297918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546297918?lang=zh_cn&edition=full","pubTime":"2025-06-25 15:20","pubTimestamp":1750836002,"startTime":"0","endTime":"0","summary":"06月25日, 欧林生物股价跌1.13%,报收15.80元,成交金额7619.4万元,换手率1.19%,振幅3.82%,量比1.46。欧林生物今日主力资金净流出852.9万元,上一交易日主力净流出233.2万元。该股近5个交易日下跌1.74%,主力资金累计净流入263.8万元;近20日主力资金累计净流出3691.0万元,其中净流出天数为13日。|06月25日主力加仓幅度排名||#|股票简称|主力净额占比|#|天晟新材|11.04%|#|新力金融|7.66%|#|北方长龙|7.56%|#|...|...|#3994|欧林生物|-0.13%|欧林生物所在的生物制品行业,今日主力净流出3.72亿元,行业排名20/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625165611a4bd00fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625165611a4bd00fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688319","BK0239"],"gpt_icon":0},{"id":"2545491460","title":"欧林生物06月23日主力净流入417.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2545491460","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545491460?lang=zh_cn&edition=full","pubTime":"2025-06-23 15:20","pubTimestamp":1750663234,"startTime":"0","endTime":"0","summary":"06月23日, 欧林生物股价涨1.45%,报收16.05元,成交金额4849.1万元,换手率0.75%,振幅3.03%,量比0.84。欧林生物今日主力资金净流入417.2万元,上一交易日主力净流出168.7万元。该股近5个交易日下跌3.14%,主力资金累计净流入2012.0万元;近20日主力资金累计净流出5268.6万元,其中净流出天数为13日。|06月23日主力加仓幅度排名||#|股票简称|主力净额占比|#|逸豪新材|8.98%|#|大为股份|7.79%|#|C新恒汇|7.30%|#|...|...|#1223|欧林生物|0.06%|欧林生物所在的生物制品行业,今日主力净流入1.96亿元,行业排名25/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623165235a7186208&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623165235a7186208&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688319"],"gpt_icon":0},{"id":"2544140833","title":"欧林生物06月20日主力净流出168.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2544140833","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544140833?lang=zh_cn&edition=full","pubTime":"2025-06-20 15:21","pubTimestamp":1750404078,"startTime":"0","endTime":"0","summary":"06月20日, 欧林生物股价跌3.18%,报收15.82元,成交金额6777.3万元,换手率1.04%,振幅5.14%,量比1.11。欧林生物今日主力资金净流出168.7万元,上一交易日主力净流入1101.5万元。该股近5个交易日下跌3.00%,主力资金累计净流入2290.8万元;近20日主力资金累计净流出5956.1万元,其中净流出天数为14日。|06月20日主力加仓幅度排名||#|股票简称|主力净额占比|#|N华之杰|25.53%|#|N新恒汇|25.40%|#|川润股份|8.72%|#|...|...|#2580|欧林生物|-0.03%|欧林生物所在的生物制品行业,今日主力净流入4.12亿元,行业排名9/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620170628a7142ea8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620170628a7142ea8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688319"],"gpt_icon":0},{"id":"2544192772","title":"生物制品行业深度报告:MNC加速布局减重降糖千亿美金赛道,开启BD黄金窗口期","url":"https://stock-news.laohu8.com/highlight/detail?id=2544192772","media":"开源证券","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544192772?lang=zh_cn&edition=full","pubTime":"2025-06-20 08:06","pubTimestamp":1750377989,"startTime":"0","endTime":"0","summary":"MNC加速布局减重降糖千亿美金赛道,开启BD黄金窗口期以司美格鲁肽与替尔泊肽为代表的GLP-1RA类药物正在彻底改变糖尿病与肥胖症的治疗范式,根据Jefferies等数据统计,2031年预计GLP-1RA类药物全球销售规模有望超过1500亿美元规模。近年来减重降糖领域重磅BD交易频发,我们预期将迎来BD黄金窗口期,国内企业相关管线将迎来历史性出海机遇。随着海外MNC加速布局该赛道,国内优质管线均有较强出海潜力,有望打开成长空间。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506200806389523e82d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506200806389523e82d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688739","688331","688520","159831","688336","688163","603087","600867","603392","603590","600161","BK0239","688185","688180","688177","688687","688136","600211","688293","688137","688488","688276","BK0033","688670","688105","688319","600739","688443","688278"],"gpt_icon":0},{"id":"2544157539","title":"欧林生物06月19日主力净流入1101.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2544157539","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544157539?lang=zh_cn&edition=full","pubTime":"2025-06-19 15:21","pubTimestamp":1750317676,"startTime":"0","endTime":"0","summary":"06月19日, 欧林生物股价涨1.62%,报收16.34元,成交金额6237.3万元,换手率0.94%,振幅3.61%,量比0.84。欧林生物今日主力资金净流入1101.5万元,上一交易日主力净流出59.3万元。该股近5个交易日下跌2.56%,主力资金累计净流入2375.4万元;近20日主力资金累计净流出5889.8万元,其中净流出天数为14日。|06月19日主力加仓幅度排名||#|股票简称|主力净额占比|#|创新医疗|9.04%|#|凯旺科技|8.35%|#|海科新源|6.34%|#|...|...|#446|欧林生物|0.17%|欧林生物所在的生物制品行业,今日主力净流出8.60亿元,行业排名23/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619171611a71234c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619171611a71234c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688319","BK0239"],"gpt_icon":0},{"id":"2544922167","title":"欧林生物06月18日主力净流出59.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2544922167","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544922167?lang=zh_cn&edition=full","pubTime":"2025-06-18 15:20","pubTimestamp":1750231246,"startTime":"0","endTime":"0","summary":"06月18日, 欧林生物股价跌0.56%,报收16.08元,成交金额2954.6万元,换手率0.45%,振幅1.55%,量比0.38。欧林生物今日主力资金净流出59.3万元,上一交易日主力净流入721.3万元。该股近5个交易日下跌7.00%,主力资金累计净流出320.0万元;近20日主力资金累计净流出7061.9万元,其中净流出天数为15日。|06月18日主力加仓幅度排名||#|股票简称|主力净额占比|#|中超控股|8.25%|#|北方长龙|7.16%|#|逸豪新材|5.79%|#|...|...|#2208|欧林生物|-0.01%|欧林生物所在的生物制品行业,今日主力净流出5.12亿元,行业排名20/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618165645a71022da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618165645a71022da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688319","BK0239"],"gpt_icon":0},{"id":"2543622181","title":"最火赛道再迎重磅利好,创新药行情还能持续多久?","url":"https://stock-news.laohu8.com/highlight/detail?id=2543622181","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543622181?lang=zh_cn&edition=full","pubTime":"2025-06-16 16:33","pubTimestamp":1750062792,"startTime":"0","endTime":"0","summary":"当下最火赛道——创新药再迎重磅利好!其中提到,为进一步支持以临床价值为导向的创新药研发,提高临床研发质效,对符合要求的创新药临床试验申请在30个工作日内完成审评审批。近期,医药股利好持续发酵。另外6月13日,石药集团宣布与阿斯利康达成合作协议,将利用AI技术平台发现和开发新型口服小分子创新药。今日尾盘,创新药依然出现了结构性大涨。那么,创新药的行情还能持续多久?展望2025,医药围绕创新药要持续乐观。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616164703a4aba967&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616164703a4aba967&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600521","BK0012","688336","603367","688710","600851","603127","BK0028","600513","688091","688131","600645","BK0185","688189","688136","688505","688222","BK0201","688317","688658","688117","688319","688550","BK0188","BK0070","688202","600721","600200","159992","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753150746984,"stockEarnings":[{"period":"1week","weight":0.2903},{"period":"1month","weight":0.4273},{"period":"3month","weight":0.406},{"period":"6month","weight":1.0053},{"period":"1year","weight":1.457},{"period":"ytd","weight":1.1302}],"compareEarnings":[{"period":"1week","weight":0.0114},{"period":"1month","weight":0.0595},{"period":"3month","weight":0.0788},{"period":"6month","weight":0.1077},{"period":"1year","weight":0.1936},{"period":"ytd","weight":0.0621}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"成都欧林生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"6219人(较上一季度增加4.63%)","perCapita":"65188股","listingDate":"2021-06-08","address":"四川省成都市郫都区高新区天欣路99号","registeredCapital":"40593万元","survey":" 成都欧林生物科技股份有限公司的主营业务是人用疫苗的研发、生产及销售。公司的主要产品是吸附破伤风疫苗、b型流感嗜血杆菌结合疫苗、A群C群脑膜炎球菌多糖结合疫苗。公司入选“中国品牌价值评价”,获得“中国产学研合作创新奖”“2023年度生产力促进(创新发展)二等奖”,并被评为“四川省技术创新示范企业”“2023年度四川省医药企业50强”。公司“严重致病菌疫苗关键技术创立及推广应用”获评“重庆市科技进步一等奖”。","listedPrice":9.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"欧林生物(688319)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供欧林生物(688319)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"欧林生物,688319,欧林生物股票,欧林生物股票老虎,欧林生物股票老虎国际,欧林生物行情,欧林生物股票行情,欧林生物股价,欧林生物股市,欧林生物股票价格,欧林生物股票交易,欧林生物股票购买,欧林生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"欧林生物(688319)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供欧林生物(688319)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}